Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 28.10.2019 / 13:18 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. - Share buy-back - 19th Interim Report In the period from October 21, 2019 until and including October 25, 2019, a total of 329,490 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 21/10/2019 13,918 61.64259 22/10/2019 227,311 58.16126 23/10/2019 - - 24/10/2019 - - 25/10/2019 - -   Chi-X Europe Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 21/10/2019 - - 22/10/2019 58,236 57.95808 23/10/2019 - - 24/10/2019 - - 25/10/2019 - -   BATS Europe Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 21/10/2019 - - 22/10/2019 19,253 57.9155 23/10/2019 - - 24/10/2019 - - 25/10/2019 - -   Turquoise Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 21/10/2019 - - 22/10/2019 10,772 57.8933 23/10/2019 - - 24/10/2019 - - 25/10/2019 - -   The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including October 25, 2019 therefore amounts to 3,645,014 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., October 28, 2019 28.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

898473  28.10.2019